| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 |
# |
Score |
Template |
Links and tools | %id | First |
LAEAVAGGRVLVVGAGGIGCELLKNLVLTGFSHIDLIDLDTIDVSNLNRQFLFQKKHVGRSKAQVAKESVLQFYPKANIVAYHDSIMNPDYNVEFFRQFILVMNALDNRAARNHVNRMCLAADVPLIESGTAGYLGQVTTIKKGVTECYECHPKPTQRTFPGCTIRNTPSEPIHCIVWAKYLFNQLFGEEDADQEVSPDRADPEAAWEPTEAEARARASNEDGDIKRISTKEWAKSTGYDPVKLFTKLFKDDIRYLLTMDKLWRKRKPPVPLDWAEVQSQGEETNASDQQNEPQLGLKDQQVLDVKSYARLFSKSIETLRVHLAEKGDGAELIWDKDDPSAMDFVTSAANLRMHIFSMNMKSRFDIKSMAGNIIPAIATTNAVIAGLIVLEGLKILSGKIDQCRTIFLNKQPNPRKKLLVPCALDPPNPNCYV | Last |
1 | -130.000 | PF00899.21; SAE2_HUMAN/11-443; ThiF family |
ali |
100 | 1 | LAEAVAGGRVLVVGAGGIGCELLKNLVLTGFSHIDLIDLDTIDVSNLNRQFLFQKKHVGRSKAQVAKESVLQFYPKANIVAYHDSIMNPDYNVEFFRQFILVMNALDNRAARNHVNRMCLAADVPLIESGTAGYLGQVTTIKKGVTECYECHPKPTQRTFPGCTIRNTPSEPIHCIVWAKYLFNQLFGEEDADQEVSPDRADPEAAWEPTEAEARARASNEDGDIKRISTKEWAKSTGYDPVKLFTKLFKDDIRYLLTMDKLWRKRKPPVPLDWAEVQSQGEETNASDQQNEPQLGLKDQQVLDVKSYARLFSKSIETLRVHLAEKGDGAELIWDKDDPSAMDFVTSAANLRMHIFSMNMKSRFDIKSMAGNIIPAIATTNAVIAGLIVLEGLKILSGKIDQCRTIFLNKQPNPRKKLLVPCALDPPNPNCYV |
433 |
2 | -38.900 | PF10585.9; W4Z0R6_STRPU/636-883; Ubiquitin-activating enzyme active site |
ali follow.. |
15 | 1 | ........................................................................................................................................................................PNAIEHTIQWARDMFEGLFRNPAENAAQYGTDPKFMERTLKMPGCQPIEVLELLKRALIDDRPKSLEDCISWTRHHFESQFVNQIKQLLSGAPFWSPKRCPHPLLFNPDNDMHLSYIVSTSNLLAAVYQAAAEANADDARLREIVDSLPTPEQLKQITIKPLDFEKDDDTNFHMDFIVATSNLRAENYGISPSDKHKTK.................................................................. |
248 |
3 | -11.000 | PF03446.15; Q8FTI1_COREF/15-184; NAD binding domain of 6-phosphogluconate dehydrogenase |
ali follow.. |
12 | 1 | ........QIGVVGLAVMGSNLARNFARNGH-TVAVYNRSTDKTDKLISDYATDGNFIPTKTVEDFVAALEKPRRAIVMVQAGAATDAVINQLDAMEEGDIIIDGNALYTDTVCREKEMAARGRHFISGGEEGALNGPSIMPGGPKESWEALGP....................................................................................................................................................................................................................................................................................... |
151 |
4 | -9.540 | PF00056.23; MDH_CHLAA/3-142; lactate/malate dehydrogenase, NAD binding domain |
ali follow.. |
13 | 2 | ........KISIIGAGFVGSTTAHWLAAKELGDIVLLDFVEGVPQGKALDLYEASPIEGFDVRVTGTNNYADTNSDVIVVTSGAPRKPGMSREDLIKVNADITRACISQAAPLSPNAVIIMVNNPL................................................................................................................................................................................................................................................................................................................... |
120 |
5 | -9.430 | PF02558.16; Q9K9R6_BACHD/6-154; Ketopantoate reductase PanE/ApbA |
ali follow.. |
17 | 1 | .........VAVIGSGSIGLLLYAYLKLAN-WPALLVTNRPEQADHLNKEGLTFVAKSGEHQPI--------------------SVTATPLSSFSAEEAEVGFITVKSFAVKALLPQLQRKKWDGLV.................................................................................................................................................................................................................................................................................................................. |
97 |
6 | -9.370 | PF00670.21; SAHH_DICDI/191-351; S-adenosyl-L-homocysteine hydrolase, NAD binding domain |
ali follow.. |
16 | 20 | ...MIAGKVAVVAGYGDVGKGCAQSLSKMGA-RVLVTEIDPINALQACETAAPLSNIF-GCRDIVRGEHFAVMKEDAIVNIGHFDCEIDVAWLNANAKKDTVKPQVDRYTLANGVHIILLAEGRLVNLGCGTG............................................................................................................................................................................................................................................................................................................ |
161 |
7 | -9.100 | PF07991.12; ILVC_METAC/15-178; Acetohydroxy acid isomeroreductase, NADPH-binding domain |
ali follow.. |
10 | 1 | ....LKDKTIAIMGYGSQGHAHARNLHESGL-NVVVGLRKGSSSWAKAESDGLKVMTVEEKAADVIMILLPDEKQASVYYSQIEPSLEAGNALVFAHGFNIHYNQIVPPKDVDVFMVAPKGPGHIVRRTYTEGVPGLIAVYQDATGKARD........................................................................................................................................................................................................................................................................................... |
149 |
8 | -8.560 | PF00208.21; DHE3_ORYSJ/176-408; Glutamate/Leucine/Phenylalanine/Valine dehydrogenase |
ali follow.. |
14 | 25 | YSESISGSTFVIQGLGNVGSWAAKLIHQKGGKIVAVGDVT-IDIPALLKHRSEGGSLEDFYGAEMDAAELLVHECDVLVPCALGGVLNRENAAEV--KARFIIEGA-NHPTDTEADEILAKKGVIVLPDIYANSGGVVVSYF................................................................................................................................................................................................................................................................................................... |
171 |
9 | -8.390 | PF01488.20; HEM1_PSEAE/169-304; Shikimate / quinate 5-dehydrogenase |
ali follow.. |
16 | 6 | IFSDLHRSQALLIGAGETITLVARHLFEQGVKRIVVANRTLERASLLAEQF-LSEIPEELANSDIVISSTASQLPILGKGAVERALKQRKHKPMFMRDIEPEVGELDDV.................................................................................................................................................................................................................................................................................................................................... |
125 |
10 | -8.330 | PF10100.9; H6NF63_9BACL/6-429; Staphylopine dehydrogenase |
ali follow.. |
12 | 1 | .......NRVLILGTGPASVQLAVTLKNKWNCCIGIAGRESVRSEPFFTALDESGRRV---RADIQNEKHQAMQGECIVDHVFQGYG------TITGEWDTLILAVTTDAYVAVLKQI........................................................................................................................................................................................................................................................................................................................... |
102 |